心脏性休克中的血管压素:病理生理学,临床证据和治疗前景
Simone Filomia1, Marco Giuseppe Del Buono1, Gianluigi Saponara1
1Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
ESC heart failure
|February 19, 2026
概括
压素是一种非上腺压缩剂,通过改善血液动力学而没有甲基荷胺副作用,在特定的心脏性休克病例中表现有前途. 为了在这个复杂的患者群体中实现最佳使用,需要进一步的研究.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 血管压素是一种用于分配性休克的血管压缩剂.
- 它在心脏性休克中的作用不太明确,但可能有益.
- 了解其机制和应用对于复杂的案例至关重要.
研究的目的:
- 综合了血管压素在心脏性休克中的药理学,血液动力学和临床应用.
- 为了确定患者的表型,可能会从压素治疗中受益.
- 批判性地评估当前的证据,并指导个性化治疗方法.
主要方法:
- 综合性文献审查和综合.
- 对药理学机制和血液动力学效应的分析.
- 临床情景和患者个人资料的划定.
主要成果:
- 血管压素可能有利于特定的心脏性休克表型 (例如,低SVR,RV失败,停顿后).
- 它的非上腺作用可以改善输液,并减少与甲基荷兰胺相关的不良影响.
- 概述了对机械循环支持的潜在有害情景和影响.
结论:
- 血管压素在被选中的心脏性休克患者中提供了一种有价值的治疗选择.
- 建议采用以生理学为导向的个性化方法.
- 需要进行前性研究,以优化这种异质人群中血管压缩剂的选择.
相关概念视频
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
Blood Pressure Imbalances and Circulatory Shock
1.7K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
Pathophysiology of Heart Failure
4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Cardiopulmonary Resuscitation IV: Pharmacological Management
952
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
952
Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K


